GONGWIN BIOPHARM CO., LTD
Update：2025/12/24
Industries
Main Industry
Biotechnology
Main Product/Service
PTS - MITTA
Founded Year
2014
Unified Business No.
24751115
Status
Active
Number of Employees
0
Total Paid-in
Capital
1,285,978,000 (NT$)
Location of Company
Taiwan
, Taipei City
Exit Status
OTC listing(2025)
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, Ministry of Economic Affairs.
Exclusive content for members
Members-only content. Please log in to access.
Introduction
Gongwin Biopharm Holdings, Co., Ltd. Cayman (Gongwin-KY; ticker: 6617), founded in 2014, is a Taiwan-based biopharmaceutical company focused on developing novel anti-cancer drugs.
In 2017, Gongwin-KY was granted the "Biotech New Drug Company" designat
In 2017, Gongwin-KY was granted the "Biotech New Drug Company" designat
